A novel nondrug SFRP1 antagonist inhibits catagen development in human hair follicles ex vivo
2020; Oxford University Press; Volume: 184; Issue: 2 Linguagem: Catalão
10.1111/bjd.19552
ISSN1365-2133
AutoresMarta Bertolini, Jérémy Chéret, Daniela Pinto, Nathan J. Hawkshaw, L. Ponce, Hanieh Erdmann, Francisco Jiménez, Wolfgang Funk, Ralf Paus,
Tópico(s)Autoimmune Bullous Skin Diseases
ResumoBritish Journal of DermatologyVolume 184, Issue 2 p. 371-373 Research Letter A novel nondrug SFRP1 antagonist inhibits catagen development in human hair follicles ex vivo M. Bertolini, orcid.org/0000-0002-5927-6998 Monasterium Laboratory, Münster, GermanySearch for more papers by this authorJ. Chéret, orcid.org/0000-0003-1901-0551 Monasterium Laboratory, Münster, Germany Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USASearch for more papers by this authorD. Pinto, orcid.org/0000-0001-8107-106X Giuliani S.p.A., Milan, ItalySearch for more papers by this authorN. Hawkshaw, orcid.org/0000-0001-5311-3840 Monasterium Laboratory, Münster, Germany Centre for Dermatology Research, University of Manchester, and NIHR Biomedical Research Centre, Manchester, UKSearch for more papers by this authorL. Ponce, orcid.org/0000-0003-4548-2341 Monasterium Laboratory, Münster, GermanySearch for more papers by this authorH. Erdmann, orcid.org/0000-0002-2054-6428 Kosmed Clinic, Hamburg, GermanySearch for more papers by this authorF. Jimenez, orcid.org/0000-0003-1676-3056 Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain Mediteknia Dermatology Clinic, Las Palmas de Gran Canaria, SpainSearch for more papers by this authorW. Funk, orcid.org/0000-0003-4480-1259 Clinic for Plastic, Aesthetic and Reconstructive Surgery, Munich, GermanySearch for more papers by this authorR. Paus, Corresponding Author rxp803@med.miami.edu orcid.org/0000-0002-3492-9358 Monasterium Laboratory, Münster, Germany Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA Centre for Dermatology Research, University of Manchester, and NIHR Biomedical Research Centre, Manchester, UK Correspondence: Ralf Paus. Email: rxp803@med.miami.eduSearch for more papers by this author M. Bertolini, orcid.org/0000-0002-5927-6998 Monasterium Laboratory, Münster, GermanySearch for more papers by this authorJ. Chéret, orcid.org/0000-0003-1901-0551 Monasterium Laboratory, Münster, Germany Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USASearch for more papers by this authorD. Pinto, orcid.org/0000-0001-8107-106X Giuliani S.p.A., Milan, ItalySearch for more papers by this authorN. Hawkshaw, orcid.org/0000-0001-5311-3840 Monasterium Laboratory, Münster, Germany Centre for Dermatology Research, University of Manchester, and NIHR Biomedical Research Centre, Manchester, UKSearch for more papers by this authorL. Ponce, orcid.org/0000-0003-4548-2341 Monasterium Laboratory, Münster, GermanySearch for more papers by this authorH. Erdmann, orcid.org/0000-0002-2054-6428 Kosmed Clinic, Hamburg, GermanySearch for more papers by this authorF. Jimenez, orcid.org/0000-0003-1676-3056 Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain Mediteknia Dermatology Clinic, Las Palmas de Gran Canaria, SpainSearch for more papers by this authorW. Funk, orcid.org/0000-0003-4480-1259 Clinic for Plastic, Aesthetic and Reconstructive Surgery, Munich, GermanySearch for more papers by this authorR. Paus, Corresponding Author rxp803@med.miami.edu orcid.org/0000-0002-3492-9358 Monasterium Laboratory, Münster, Germany Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA Centre for Dermatology Research, University of Manchester, and NIHR Biomedical Research Centre, Manchester, UK Correspondence: Ralf Paus. Email: rxp803@med.miami.eduSearch for more papers by this author First published: 16 September 2020 https://doi.org/10.1111/bjd.19552Citations: 1 Funding sources: The study was supported by Giuliani S.p.A., Milan, Italy. Conflicts of interest: M.B., J.C., N.H. and L.P. are or were employees or consultants of Monasterium Laboratory, a contract research organization performing contracted research in the field of dermatology, for which R.P. serves as CEO. R.P. is also a consultant of Giuliani S.p.A., while D.P. is an employee; Giuliani S.p.A. has filed a patent (P020378WO-01) for the use of imino-oxothiazolidine derivatives in the cosmetic and trichological field. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume184, Issue2February 2021Pages 371-373 RelatedInformation
Referência(s)